News & Media – Page 4 – Community Voices 340B

On July 11, the U.S. House Appropriations Committee emphasizes the importance of the 340B program in HHS report

Hot topics, UncategorizedBy Rhiannon Klein July 29, 2021

On July 11, the U.S. House Appropriations Committee approved the fiscal year (FY) 2022 appropriations bill (the “Bill”) and accompanying report for the Department of Labor, HHS, Education, and Related Agencies. The accompanying report calls for HRSA to report on actions it is taking to (1) safeguard safety-net providers’ access to discounted drugs, including those dispensed at contract pharmacies, and…

Details

Secretary of Health and Human Services (HHS) appoints of the much-awaited 340B Alternative Dispute Resolution (ADR) Board

Hot topics, UncategorizedBy Rhiannon Klein July 1, 2021

340B Safety net providers laud the Secretary of Health and Human Services’ (HHS) appointment of the much-awaited 340B Alternative Dispute Resolution (ADR) Board on June 21, 2021. Members of the ADR Board will serve as ADR Panelists to resolve disputes between 340B safety-net providers and drug companies. Beginning in the summer of 2020, several drug manufacturers have…

Details

Secretary Becerra Provides Important Insight on 340B at the U.S. Senate Appropriations Sub-Committee

Hot topics, UncategorizedBy Rhiannon Klein June 15, 2021

On June 9, 2021, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations subcommittee. In his testimony, Secretary Becerra provided important insight into HHS’s stance regarding six drug companies’ unilateral actions to halt 340B pricing on drugs shipped to contract pharmacies. Senator Manchin stated his interest in…

Details

White House Budget Office Approves Plan to Rescind Controversial Trump-Era Insulin Rule

Hot topics, UncategorizedBy Rhiannon Klein June 10, 2021

Earlier this week, the White House Office of Management and Budget (OMB) completed its review of HHS’ proposal to rescind the Trump Administration’s final rule that would require federally qualified health centers (FQHCs) to provide insulin and injectable epinephrine to low-income patients at the price the FQHC pays for those drugs under the 340B program.…

Details

Tennessee Governor Enacts Law to Protect 340B Covered Entities from Discriminatory Reimbursement Practices

Hot topics, UncategorizedBy Rhiannon Klein June 1, 2021

Last week, Tennessee Governor Bill Lee signed into a law a bill that will protect 340B covered entities and their contract pharmacies from discriminatory reimbursement practices commonly employed by pharmacy benefit managers (PBMs) and third party payers and will help to bring pricing transparency to Tennessee’s healthcare system (HB 1398/SB 1617). The law prohibits…

Details

340B ‘Instrumental’ in Family Health Center of Kalamazoo Vaccinating Community

340B StoriesBy Rhiannon Klein May 27, 2021

Family Health Centers of Kalamazoo in Kalamazoo, Michigan has been busy these past few months running back-to-back COVID-19 vaccine clinics. As of last week, FHC had run 52 clinics in the greater Kalamazoo area, administering 8,112 vaccines to people in the community. The 340B Drug Discount Program allowed FHC to serve more patients and get…

Details

CV340B’s Northeast Regional Advocacy Plans ‘340B in the Northeast’ Webinar for May 25th, 2021

CV340B UpdateBy Rhiannon Klein May 20, 2021

CV340B’s Northeast Regional Advocacy Group is hosting a webinar titled ‘340B in the Northeast’ scheduled for 11:00am- 12:00pm on Tuesday May 25th, 2021. Webinar will include a brief history of the 340B Drug Pricing Program, current threats to the program, a panel of Northeastern providers and a discussion on advocacy. The panel will discuss how…

Details

HRSA Determines Six Manufacturers’ Contract Pharmacy Policies Violate 340B Statute

Hot topics, UncategorizedBy Rhiannon Klein May 18, 2021

Yesterday, HRSA Acting Administrator Diana Espinosa sent letters to Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics making clear to the manufacturers that their restrictions on access to 340B pricing at contract pharmacies “have resulted in overcharges and are in direct violation of the 340B statute.” As a result, HRSA is requiring the six manufacturers…

Details

340B providers filed an amicus brief in opposition to AstraZeneca’s motion to invalidate Advisory Opinion.

Hot topics, UncategorizedBy Rhiannon Klein May 13, 2021

On May 4, 2021, 340B safety-net providers and their trade associations filed a brief in the case brought by AstraZeneca Pharmaceuticals LP (AstraZeneca) against the U.S. Department of Health and Human Services (HHS) seeking to invalidate the former HHS General Counsel’s 2020 Advisory Opinion on contract pharmacy arrangements. The brief was filed jointly with the…

Details

Arkansas Passes Comprehensive 340B Anti-Discriminatory Reimbursement Bill, Protects Covered Entities Rights to Use Contract Pharmacies

Hot topics, UncategorizedBy Rhiannon Klein May 4, 2021

Last week, Arkansas passed legislation (HB 1881) intended to address 340B discriminatory pricing practices by third party payers and pharmacy benefit managers (PBMs). The law also addresses drug manufacturers denying access to 340B pricing at contract pharmacies. The bill has been sent to Governor Asa Hutchinson for his signature. The “340B Drug Pricing Nondiscrimination…

Details